Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome

被引：6

作者：

Isaacsohn, JL

Troendle, AJ

Orloff, DG

机构：

[1] Medpace Inc, Cincinnati, OH 45212 USA

[2] US FDA, Rockville, MD USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 93卷 / 11期

关键词：

D O I：

10.1016/j.amjcard.2004.02.007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：49C / 52C

页数：4

共 50 条

[1] Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus
Brunzell, JD
Ayyobi, AF
[J]. AMERICAN JOURNAL OF MEDICINE, 2003, 115 : 24 - 28
[2] Therapeutic approaches to dyslipidemia in diabetes mellitus and metabolic syndrome
Cottrell, DA
Marshall, BJ
Falko, JM
[J]. CURRENT OPINION IN CARDIOLOGY, 2003, 18 (04) : 301 - 308
[3] Pathophysiology of dyslipidemia in patients with metabolic syndrome or type 2 diabetes mellitus
Verges, Bruno
[J]. NUTRITION CLINIQUE ET METABOLISME, 2007, 21 (01): : 9 - 16
[4] Mixed Dyslipidemia, Metabolic Syndrome, Diabetes Mellitus, and Cardiovascular Disease: Clinical Implications
Cannon, Christopher P.
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12A): : 5L - 9L
[5] A Review of the Current Status of the Management of Mixed Dyslipidemia Associated with Diabetes Mellitus and Metabolic Syndrome
Davidson, Michael
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12A): : 19L - 27L
[6] Nonpharmacologic Management of Mixed Dyslipidemia Associated with Diabetes Mellitus and the Metabolic Syndrome: A Review of the Evidence
Stone, Neil J.
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12A): : 14L - 18L
[7] Combination therapy of dyslipidemia in non-insulin-dependent diabetes mellitus and the metabolic syndrome
Rembold C.M.
[J]. Current Diabetes Reports, 2004, 4 (5) : 330 - 334
[8] Progranulin, a New Adipokine at the Crossroads of Metabolic Syndrome, Diabetes, Dyslipidemia and Hypertension
Korolczuk, Agnieszka
Beltowski, Jerzy
[J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (10) : 1533 - 1539
[9] The path to approval of new drugs for diabetes
Rendell, Marc
[J]. EXPERT OPINION ON DRUG SAFETY, 2013, 12 (02) : 195 - 207
[10] Metabolic syndrome and diabetes mellitus
Feeman, WE
[J]. CIRCULATION, 2004, 109 (03) : E23 - E23

← 1 2 3 4 5 →